Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial

G. Jenkins (Nottingham, United Kingdom), I. Noth (Charlottesville, Virginia, United States of America), M. Selman (Mexico City, Mexico), V. Cottin (Lyon, France), Y. Nishioka (Tokushima, Japan), J. Song (Seoul, Republic of Korea), A. Prasse (Hannover, Germany), E. White (Ann Arbor, Michigan, United States of America), C. Ittrich (Biberach an der Riss, Germany), C. Diefenbach (Biberach an der Riss, Germany), K. Rohr (Ingelheim am Rhein,, Germany), S. Stowasser (Ingelheim am Rhein,, Germany), T. Maher (London, United Kingdom)

Source: Virtual Congress 2020 – Promising biomarkers for idiopathic interstitial pneumonia
Session: Promising biomarkers for idiopathic interstitial pneumonia
Session type: Oral Presentation
Number: 5187
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Jenkins (Nottingham, United Kingdom), I. Noth (Charlottesville, Virginia, United States of America), M. Selman (Mexico City, Mexico), V. Cottin (Lyon, France), Y. Nishioka (Tokushima, Japan), J. Song (Seoul, Republic of Korea), A. Prasse (Hannover, Germany), E. White (Ann Arbor, Michigan, United States of America), C. Ittrich (Biberach an der Riss, Germany), C. Diefenbach (Biberach an der Riss, Germany), K. Rohr (Ingelheim am Rhein,, Germany), S. Stowasser (Ingelheim am Rhein,, Germany), T. Maher (London, United Kingdom). Effects of nintedanib on markers of epithelial damage in subjects with IPF: data from the INMARK trial. 5187

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: